HCMT
EGRX

Highland Capital Management (Texas)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Highland Capital Management (Texas)’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-43,400
Closed -$1.68M – 374
2016
Q2 		$1.68M Sell
43,400
-17,681
-29% -$736K 0.07% 167
2016
Q1 		$2.47M Buy
+61,081
New +$3.88M 0.11% 153
2015
Q4 		– Sell
-239,508
Closed -$17.7M – 293
2015
Q3 		$17.7M Buy
+239,508
New +$19.9M 0.52% 52

Other funds holding EGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Highland Capital Management (Texas)'s EGRX Position: Q3 2016 in Review

Highland Capital Management (Texas) sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2016, closing a stake of 43,400 shares — an estimated $1.68M sold.

Highland Capital Management (Texas) first reported a position in EGRX in Q3 2015 and held it in 3 quarters. The position peaked at $17.7M in Q3 2015. 137 funds tracked by Wall St. Rank hold EGRX as of Q3 2016.

  • Highland Capital Management (Texas) reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 43,400 Eagle Pharmaceuticals, Inc. shares in Q3 2016, an estimated $1.68M.
  • Highland Capital Management (Texas) first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • Highland Capital Management (Texas)'s Eagle Pharmaceuticals, Inc. position peaked at $17.7M in Q3 2015.
  • 137 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2016.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2016, filed 14 Nov 2016.